We consent to the incorporation by reference in this Registration Statement on Form S-3 of Galectin Therapeutics, Inc. (the “Company”) of
our report dated March 31, 2026, relating to the consolidated financial statements for the Company appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.
We also consent to the reference to our firm under the caption “Experts” in the Prospectus, which is part of this Registration Statement.